APT Medical Inc (688617) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.093x

Based on the latest financial reports, APT Medical Inc (688617) has a cash flow conversion efficiency ratio of 0.093x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥294.68 Million ≈ $43.12 Million USD) by net assets (CN¥3.18 Billion ≈ $465.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of APT Medical Inc for the company's overall valuation and market capitalisation.

APT Medical Inc - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how APT Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

APT Medical Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of APT Medical Inc ranked by their cash flow conversion efficiency. Explore 688617 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Budimex S.A.
WAR:BDX
-0.016x
Sinomach Precision Industry Co Ltd
SHE:002046
-0.034x
NEPI Rockcastle PLC
AS:NRP
0.034x
VEND MARKETPLACES ASA
OL:VEND
0.027x
Luzerner Kantonalbank AG
SW:LUKN
0.004x
Enstar Group Limited
NASDAQ:ESGR
0.023x
Wyndham Hotels & Resorts Inc
NYSE:WH
0.190x
Compagnie Generale des Etablissements Michelin SCA
LSE:0OFM
0.069x

Annual Cash Flow Conversion Efficiency for APT Medical Inc (2017–2025)

The table below shows the annual cash flow conversion efficiency of APT Medical Inc from 2017 to 2025. View latest APT Medical Inc stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.18 Billion
≈ $465.03 Million
CN¥975.30 Million
≈ $142.72 Million
0.307x +5.47%
2024-12-31 CN¥2.55 Billion
≈ $373.85 Million
CN¥743.39 Million
≈ $108.78 Million
0.291x -17.15%
2023-12-31 CN¥1.96 Billion
≈ $287.10 Million
CN¥689.06 Million
≈ $100.83 Million
0.351x +71.18%
2022-12-31 CN¥1.79 Billion
≈ $262.09 Million
CN¥367.46 Million
≈ $53.77 Million
0.205x +102.58%
2021-12-31 CN¥1.79 Billion
≈ $262.09 Million
CN¥181.39 Million
≈ $26.54 Million
0.101x -69.25%
2020-12-31 CN¥450.09 Million
≈ $65.86 Million
CN¥148.24 Million
≈ $21.69 Million
0.329x +107.52%
2019-12-31 CN¥345.90 Million
≈ $50.62 Million
CN¥54.90 Million
≈ $8.03 Million
0.159x +130.60%
2018-12-31 CN¥270.70 Million
≈ $39.61 Million
CN¥18.63 Million
≈ $2.73 Million
0.069x +14.29%
2017-12-31 CN¥214.43 Million
≈ $31.38 Million
CN¥12.91 Million
≈ $1.89 Million
0.060x --

About APT Medical Inc

SHG:688617 China Medical Devices
Market Cap
$5.04 Billion
CN¥34.45 Billion CNY
Market Cap Rank
#3571 Global
#496 in China
Share Price
CN¥243.42
Change (1 day)
-0.03%
52-Week Range
CN¥181.27 - CN¥331.86
All Time High
CN¥453.00
About

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more